Aston Sci Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aston Sci Inc . Real-time updates on events, politics, business and more.

US FDA Approves Aston Sci.'s Phase 2 IND for Ovarian Cancer Vaccine, AST-201

September 12, 2023

/PRNewswire/ -- Aston Sci. is proud to announce that it has received Phase 2 Clinical Investigational New Drug (IND) approval from the U.S. Food and Drug...

United States Soult Ukpyolsi South Korea Shun Jung Public Affairs Rd Division At Aston Sci

Source: prnewswire.com

Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

September 2, 2022

/PRNewswire/ -- Aston Sci. Inc., a clinical stage biopharmaceutical company specializing in clinical development of therapeutic cancer vaccines, announced that...

Soult Ukpyolsi South Korea United States Maryl Nora Disis Eun Kyo Joung University Of Washington

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Aston Sci Inc News Today

US FDA Approves Aston Sci.'s Phase 2 IND for Ovarian Cancer Vaccine, AST-201

Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

Explore More Categories